Table 3.
Treatment history of glaucoma patients.
| Parameters | Filtering Surgery (n (%)) |
Canaloplasty (n (%)) |
SLT (n (%)) |
Monotherapy (n (%)) |
Bitherapy (n (%)) |
Tritherapy (n (%)) |
Quadric Therapy (n (%)) |
|---|---|---|---|---|---|---|---|
| Groups | |||||||
| Group A | 1 (2.7%) | 4 (10.8%) | 1 (2.7%) | 21 (56.8%) | 9 (24.3%) | 1 (2.7%) | 1 (2.7%) |
| Group B | 6 (12.5%) | 14 (29.2%) | 2 (4.2%) | 10 (20.8%) | 13 (27.9%) | 5 (10.4%) | 0 (0.0%) |
| Group C | 7 (18.2%) | 6 (26.9%) | 1 (3.8%) | 5 (19.2%) | 7 (26.9%) | 5 (19.2%) | 5 (7.7%) |
n—number, SLT—selective laser trabeculoplasty. Anti-glaucoma medications included alpha two adrenergic agonists, beta-blockers, carbonic anhydrase inhibitors, and prostaglandins.